|Transcatheter Aortic-Valve Replacement (TAVR) with a Balloon-Expandable Valve in Low-Risk Patients|
|At 71 centers, 1000 patients underwent randomization.
Among patients with severe aortic stenosis who were at low surgical risk, the rate of the composite of death, stroke, or rehospitalization at 1 year was significantly lower with TAVR than with surgery.
|Mack MJ et al.||The New England Journal of Medicine, March 16, 2019, DOI: 10.1056/NEJMoa1814052|
|This is a post of a scientific or business information. The information given here is checked thoroughly by “Implant-Register”. However we can´t be responsible for the content. Contact the publisher, if you have questions. You may inform us about changes of the information to improve the Register.|
let us know